Q32 Bio Inc. financial data

Symbol
QTTB on Nasdaq
Location
830 Winter Street, Waltham, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 531 % +23.6%
Debt-to-equity 4.33K %
Return On Equity -2.71K % -3153%
Return On Assets -61.2 % -24.3%
Operating Margin 528 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.2M shares +1.14%
Common Stock, Shares, Outstanding 12.2M shares +1.69%
Entity Public Float 136M USD +198%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 12.2M shares +1.95%
Weighted Average Number of Shares Outstanding, Diluted 12.2M shares +1.95%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Revenue from Contract with Customer, Excluding Assessed Tax 1.16M USD -64%
Research and Development Expense 37.2M USD -4.81%
General and Administrative Expense 17.6M USD +21%
Operating Income (Loss) -54.7M USD +17.5%
Nonoperating Income (Expense) 2.46M USD -78.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -87.1M USD -7369%
Income Tax Expense (Benefit) 21K USD -93.4%
Net Income (Loss) Attributable to Parent -52.3M USD +8.31%
Earnings Per Share, Basic -6 USD/shares +94.6%
Earnings Per Share, Diluted 0 USD/shares +99.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 54.8M USD -43.9%
Other Assets, Current 77K USD +51%
Assets, Current 58.3M USD -47.7%
Property, Plant and Equipment, Net 1.16M USD -25.3%
Operating Lease, Right-of-Use Asset 5.42M USD -9.97%
Other Assets, Noncurrent 570K USD -48%
Assets 66.1M USD -46.8%
Accounts Payable, Current 910K USD -63.4%
Employee-related Liabilities, Current 1.49M USD -63.6%
Accrued Liabilities, Current 4.4M USD -60.1%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 11.5M USD -32.9%
Operating Lease, Liability, Noncurrent 5.3M USD -11%
Other Liabilities, Noncurrent 55M USD 0%
Liabilities 78.4M USD -13.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -255M USD -25.8%
Stockholders' Equity Attributable to Parent -12.2M USD -137%
Liabilities and Equity 66.1M USD -46.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.5M USD +14.2%
Net Cash Provided by (Used in) Financing Activities 99.3M USD +662207%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 12.2M shares +1.69%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.47M USD -96%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 55.5M USD -43.6%
Deferred Tax Assets, Valuation Allowance 107M USD +94%
Deferred Tax Assets, Gross 109M USD +90.2%
Operating Lease, Liability 5.95M USD -18.5%
Depreciation 100K USD 0%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -52.3M USD +8.32%
Lessee, Operating Lease, Liability, to be Paid 7.59M USD -19.3%
Property, Plant and Equipment, Gross 2.82M USD +2.17%
Operating Lease, Liability, Current 651K USD -51.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.09M USD +3.02%
Lessee, Operating Lease, Liability, to be Paid, Year One 530K USD -58.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.64M USD -22.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.12M USD +2.93%
Deferred Tax Assets, Operating Loss Carryforwards 88.6M USD +15.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.16M USD +3.03%
Additional Paid in Capital 243M USD +2.77%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 5.24M USD +104%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares